Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for Endometrial Cancer
43 locations incl. Washington D.C.
Sponsor: Genmab
Sex: Female·Age: 18+
Code: NCT07166094·Phase 3·Recruiting